Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Danvantar Biophotonics Oy
OY
Active
Y-tunnus 3256143-5
Pl 176, 00101
Helsinki
Manufacture of irradiation, electromedical and electrotherapeutic equipment
·
NACE 2660
Est. 2021 · 4 years old
— employees
Share
Finland
/
Companies
/
Manufacture of irradiation, electromedical and electrotherapeutic equipment
/
Danvantar Biophotonics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
EUR thousands
Item
2024
2023
2022
Revenue
0
278
0
Staff expenses
−228
−280
−206
EBITDA
−135
−144
−221
Depreciation & amort.
−0
−0
−0
EBIT
−135
−144
−221
Net financials
−7
−0
−0
Profit before tax
−142
−144
−221
Tax
−0
−0
−0
Net profit
−142
−144
−221
Balance sheet
EUR thousands
Item
2024
2023
2022
Total assets
715
675
284
Equity
390
339
239
Long-term debt
261
0
—
Short-term debt
63
253
45
Total debt
325
336
45
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2022
2024
Equity ratio
54,6 %
This company
38,2 %
Market median
This company
Market median
43% above market
2022
2024
Return on equity
−36,3 %
This company
18,4 %
Market median
This company
Market median
297% below market
2022
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2022
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2022
2024
Debt / equity
0,83×
This company
0,62×
Market median
This company
Market median
34% above market
2022
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
More on Danvantar Biophotonics Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
